Subscribe
Home
Issues
Online First
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
Value-Based Care in Myeloma
Tracy Baroni-Allmon, BS Pharm, JD
Head, Global Oncology Access &
Reimbursement Policy
Takeda
Authored Articles
The Future of Accelerated Approval: Evolving to Better Serve Cancer Patients
Tracy Baroni-Allmon, BS Pharm, JD
,
Andrea Ferris, MBA
,
Ryan Hohma, JD
,
Paul Jeffrey, PharmD
,
Robert Orlowski, MD, PhD
,
Andrew Robertson, PhD, JD
,
Nicholas J. Sarlis, MD, PhD, FACP
Webinars
Videos
— June 8, 2022
Read Article
Top Trending Articles
1.
FDA Approves Pivekimab Sunirine-Pvzy for BPDCN
2.
FDA Approves Acalabrutinib and Venetoclax Combination for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
3.
FDA Launches Unified Adverse Event Monitoring System to Enhance Transparency and Efficiency
Home
Issues
Online First
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
Value-Based Care in Myeloma